Indeed, transcriptome analysis demonstrated an increase of FASN in HER2 + BC cell lines in comparison with HER2-negative cells, and a reduction of FASN expression as a consequence of HER2 inhibition (Kumar-Sinha et al. 2003). Here, ERBB2 is linked to breast cancer.